FIGO Grade 2 Endometrial Cancer Treatment Guide

Quick Answer

If youve just heard the phrase FIGO grade2 treatment, the short answer is: most women start with surgerytotal hysterectomy with removal of both ovariesand then consider radiation only if certain risk factors are present. In many cases, the surgery alone is enough to give a very good chance of cure.

Why Grade Matters

What does FIGO grade2 mean?

FIGO (International Federation of Gynecology and Obstetrics) grades endometrial tumors based on how much of the tissue looks like normal glands. Grade2 sits in the middle: roughly 650% of the tumor shows solid, nonglandular growth. Its more aggressive than grade1 but not as aggressive as grade3.

How does grade affect prognosis?

Studies consistently show that women with grade2 disease, especially when caught at an early stage (stageIII), enjoy a fiveyear survival rate above 85%. The risk of the cancer coming back is higher than with grade1 but still far lower than the 50plus percent seen with grade3. In plain language, grade2 is the middle child it needs attention, but the outlook is usually usually very positive when treated correctly. For patients considering longterm outcomes after removing reproductive organs, reading about survival without prostate can provide perspective on recovery and quality of life after major cancer surgery.

Realworld example

Take Maya, a 58yearold who was diagnosed after a routine pelvic exam. Her tumor was classified as FIGO grade2, stageIB. She underwent a total hysterectomy with bilateral salpingooophorectomy and, because no highrisk features were found, she did not receive radiation. Two years later shes cancerfree and back to gardening on weekends. Stories like Mayas remind us that grade2 often means treatable and survivable.

Surgery First

What surgery is recommended?

The cornerstone of FIGO grade2 endometrial cancer treatment is a total hysterectomy (removal of the uterus) plus bilateral salpingooophorectomy (removal of both ovaries and fallopian tubes). Many surgeons also remove pelvic and sometimes paraaortic lymph nodes to see if the cancer has spread.

Do I need lymphnode removal?

Not every patient. Current guidelines suggest a riskadjusted approach: if the tumor is deeply invasive or shows lymphvascular space involvement, nodes are usually taken. If the tumor is shallow and lowrisk, the surgeon may skip it to reduce surgical morbidity.

Preparing for surgery a checklist

Step	Why it matters
Preop blood work	Checks anemia, kidney function, clotting
Imaging (CT/MRI)	Looks for spread beyond the uterus
Fertility discussion	Important if youre considering future pregnancy
Ask about pain control plan	Helps you recover faster

Radiation Choices

When is radiation needed?

Radiation isnt automatically added for every FIGO grade2 case. It becomes a partner when you have any of the following:

• Deep myometrial invasion (beyond half the uterine wall)
• Lymphvascular space involvement
• Positive or close surgical margins
• Unfavorable histology (e.g., serous features)

Internal brachytherapy vs. external beam

Vaginal brachytherapy delivers radiation directly to the top of the vagina, sparing nearby organs. Its the goto for many earlystage, grade2 women who need extra insurance against local recurrence. Externalbeam radiation therapy (EBRT) covers a larger areapelvis and sometimes abdomenand is reserved for higherrisk scenarios.

What the research says

A large analysis of over 4,000 patients showed that adding vaginal brachytherapy to surgery reduced vaginal recurrences without a survival benefit for lowrisk stage1AG2 disease. In other words, if youre lowrisk, you might skip radiation altogether and still do great.

Decisionmaking flowchart (simplified)

Step1: Surgery completed.
Step2: Does pathology show any highrisk features?

• No Observation (no radiation).
• Yes Discuss brachytherapy (if risk limited to vagina) or EBRT (if deeper spread).

Chemo & Targeted

Is chemotherapy necessary for grade2?

Usually not for earlystage (III) disease if the surgery removed everything cleanly. Chemotherapy becomes part of the plan for stageIIIII disease, especially when nodes are positive or the tumor shows aggressive behavior.

Typical regimen

The standard combo is carboplatin plus paclitaxel, given every three weeks for 36 cycles. This partnership attacks cancer cells that might be hiding after surgery.

New horizons: immunotherapy and HER2

Researchers are testing pembrolizumab (an immune checkpoint inhibitor) and trastuzumab (an HER2targeted drug) for highgrade endometrioid cancers that overexpress HER2. The trials are promising, but theyre still experimental for most grade2 patients.

Quick tip

If your doctor mentions chemo, ask about the expected sideeffects, duration, and whether a clinical trial might be a better match for your situation.

FollowUp Care

Surveillance schedule

After you finish treatment, the usual followup looks like this:

• Every 34months for the first 2years
• Every 6months for years35
• Annually thereafter

Each visit typically includes a pelvic exam, a look at any vaginal cuff cytology, and imaging only if something feels off.

Redflag signs

Call your doctor right away if you notice:

• Pain or pressure in the pelvis
• Unusual bleeding or discharge
• Sudden weight loss or fatigue

Emotional checkpoint

Its normal to feel a little jittery during those first months. Many patients find comfort in joining support groups (online or inperson) where stories like Mayas become a source of hope and practical tips.

Balancing Benefits & Risks

Benefits of surgeryfirst

Removing the primary tumor gives the best chance for cureusually over an 85% fiveyear survival for earlystage grade2 disease. It also provides the most accurate pathology, which guides any further treatment.

Potential downsides

Major surgery carries risks: bleeding, infection, and a permanent menopause if the ovaries are removed. Radiation can cause bowel or bladder irritation, and chemotherapy brings nausea, fatigue, and hair loss. The key is to weigh these sideeffects against the added protection they might give.

Questions to ask your oncologist

• Do I have any highrisk features that would make radiation worthwhile?
• What are the chances of recurrence with surgery alone?
• How will menopause affect my longterm health, and can hormone therapy be considered?
• Are there clinical trials suitable for me?

Patientcentered decision aid

Put pen to paper (or phone notes) and list your prioritieslongevity, quality of life, fertility, recovery time. Compare each treatment option against those priorities. This simple exercise often clears the fog and empowers you to make a confident choice.

Conclusion

FIGO grade2 endometrial cancer sits in that middle ground where treatment is both effective and nuanced. Most women achieve excellent outcomes with a hysterectomy and bilateral oophorectomy; radiation is added only when particular risk factors tip the scales. Chemotherapy and newer targeted therapies step in for more advanced stages. By staying informed, asking the right questions, and partnering with a trusted gynecologic oncologist, you can navigate the journey with confidence and hope. If youre ready to dive deeper, consider downloading a free treatmentdecision checklist or reaching out to a nurse navigator for personalized guidance.